Last week, readers were most interested in a story about a PCR test from Roche for vaginitis getting CE marking.

Alzpath said Monday that it has licensed a proprietary Alzheimer's disease biomarker to Siemens Healthineers for use in an assay for the brain disorder. The deal covers an antibody to ...

Jefferies analyst Tycho Peterson cited the large addressable market for the company's PreTRM blood test for assessing pregnant women's risk of preterm birth.

Should the €6.3 million effort prove successful, it could lead to the adoption of Volition's assay for routine clinical use across France.